Jared Stein
Founder and Partner @ Monogram Capital Partners
Los Angeles, United States
Jared Stein is a Series B investor at Monogram Capital Partners in Los Angeles focused on Health Care and Food and Beverage. Jared Stein is the Founder and Partner at Monogram Capital Partners.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 86%
Last updated:
For AI agents: llms.txt
Industries Jared Stein invests in
Stages Jared Stein invests in
Countries Jared Stein invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $7.1M–$15M
- Series B
- $10M–$42M
- Series C
- $12M–$100M
Investment Focus
Industry
- Health Care 4 (29%)
- Food and Beverage 4 (29%)
- Wellness 3 (21%)
- E-Commerce 2 (14%)
- Food Processing 2 (14%)
Stage
- Series B 4 (29%)
- Series C 3 (21%)
- Seed 2 (14%)
- Private Equity 2 (14%)
- Series A 1 (7%)
Country
- United States 9 (64%)
- Australia 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
The Vasco Group
|
The Vasco Group is a construction firm offering commercial paving, sports construction and sports surfacing. | Private Equity / Apr 16, 2025 | |
Human Health
|
Human aims to assist medical professionals and patients to make more statistics selections. | $7.1M / Seed / Jul 25, 2022 | |
Olipop
|
OLIPOP is the clinically backed consumer beverage that meets consumer’s real-world taste preferences in a delicious tonic that benefits the microbiome, digestive function and metabolic health. | $30M / Series B / Feb 01, 2022 | |
Foxtrot
|
Foxtrot is a mobile app that lets customers shop their curated collections of drinks, food, and everyday essentials. The customer's order will be delivered straight to them in under an hour. The company was co-founded by Mike LaVitola with Brian Jaffee and Taylor Bloom in 2013 in Chicago, Illinois. | $100M / Series C / Jan 11, 2022 | |
Genexa
|
We’re Genexa and we’re the first clean medicine company Founded by two dads on a mission to revolutionize the medicine aisle, Genexa makes medicine with the same active ingredients people need, but without the artificial ones they don’t. We believe people deserve better. That’s why our business is built on the commitment to put people overeverything. All of our products are made to the highest standards of clean with no dyes, allergens, or unnecessary chemicals. It’s real medicine, made clean. Learn how we’re putting people over everything, in everything we do, at Genexa.com. | $60M / Series A / Jul 14, 2021 | |
Foundry Brands
|
Foundry is a brand acquisition platform setting a new standard for e-commerce performance and brand excellence with its data-driven technology platform. | $100M / Private Equity / Jul 12, 2021 | |
|
Foxtrot
|
Foxtrot is a mobile app that lets customers shop their curated collections of drinks, food, and everyday essentials. The customer's order will be delivered straight to them in under an hour. The company was co-founded by Mike LaVitola with Brian Jaffee and Taylor Bloom in 2013 in Chicago, Illinois. | $42M / Series B / Feb 22, 2021 | |
Vessel
|
Vessel is an at-home wellness tracker that helps in accessing, understanding, and optimizing health and wellness from the comfort of home. With Vessel, users can test 10 different health metrics in less than 10 minutes for around $10. Vessel works with some of the best doctors, nutritionists, and scientists to create its wellness cards and buildfood, supplement, and lifestyle recommendations tailored based on the results. A variety of membership plans enables one to see how diet, supplements, and lifestyle affect the body over time so users can start to feel and perform better. With Vessel, the science of feeling great fits in the palm of the hand. | $14.5M / Seed / Jan 27, 2021 | |
Vive Organic
|
Vive Organic is an organic, function-focused line dedicated to providing the highest quality wellness shots. It has assessed hundreds of farms around the world, and exclusively source their ingredients from the top tier of organic farms. It never uses artificial colors or any type of sweeteners – not even stevia, honey, or sugar. They believe thatnature alone should determine the color and flavor of its Wellness Shots.It was founded in 2015 and is headquartered in Venice, California. | $13M / Series B / Jul 23, 2020 | |
Kidfresh
|
Kidfresh creates all-natural kids’ meals it provides top nutrition with no artificial colors or flavors to kids. Kidfresh is now offering a line of six healthy kids’ meals all-natural, frozen meals for kids sold in the US at retailers such as Whole Foods, Shaws, ShopRite, and a growing list of other supermarkets.The company was founded in 2016and headquartered in New York, United States. | Venture - Series Unknown / Feb 26, 2020 | |
| See all 14 investments → | |||
Co-Investors
Monogram Capital Partners is a private equity investment firm focused exclusively on consumer and retail companies.The partners have invested more than $1.4 billion of equity capital primarily in consumer and retail businesses. Leveraging best practices and relationships from leading institutions, bring elite investing and advisory experience tothe lower middle market.In partnership with management teams, the firm focuses on developing the next generation of category leaders by providing flexible capital, deep domain knowledge, and access to transformative industry relationships.
Monogram Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jared Stein
Founder and Partner
|
|||
Michael Li
Associate
|
|||
|
Caroline Chmiel
Associate
|
|||
Lusa Zhou
Principal
|
|||
Natasha Burke
Executive Coordinator
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Jared Stein invest in?
Jared Stein invests primarily in Health Care, Food and Beverage and Wellness startups, most often at Series B and Series C stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Jared Stein's check size?
Jared Stein typically joins rounds of $7.1M–$15M at Seed, $10M–$42M at Series B and $12M–$100M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Jared Stein participates in.
How do I contact Jared Stein?
Public channels for Jared Stein include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jared Stein last invest?
The most recent investment recorded for Jared Stein closed in Apr 2025. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
